Immunosuppressive Total Lymphoid Irradiation-Based Reconditioning Regimens Enable Engraftment After Graft Rejection or Graft Failure in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation
Creators
- 1. Department of Radiation Oncology, University of Tuebingen, Tuebingen (Germany)
- 2. Department of Pediatric Hematology and Oncology, University of Tuebingen, Tuebingen (Germany)
- 3. Department of Bone Marrow Transplantation, University of Essen, Essen (Germany)
- 4. Department of Internal Medicine II, University of Tuebingen, Tuebingen (Germany)
Description
Purpose: To retrospectively evaluate the efficacy of total lymphoid irradiation (TLI)-based reconditioning regimens in patients with graft failure or graft rejection after allogeneic hematopoietic stem cell transplantation. Methods and Materials: The results of 14 patients (7 adults and 7 children) with a variety of hematologic malignant diseases treated with a TLI-based reconditioning regimen with 7-Gy single-dose application plus anti-T-lymphocyte antibody OKT3 (n = 11) and/or antithymocyte globulin (n = 7)/fludarabine (n = 9), followed by an infusion of peripheral blood stem cells (n = 13) or bone marrow stem cells (n = 1) from related or unrelated donors, were retrospectively analyzed. Results: Of the 14 recipients, the data from 11 were evaluable for engraftment after TLI-based reconditioning because 3 adults died early (at Day 2, 5, and 15) after the second transplantation of infectious complications. Engraftment in 4 adults was seen after a median of 12 days (range, 10-18) and occurred after a median of 10 days (range, 9-32) in the 7 children. TLI-based reconditioning was well-tolerated with no severe toxicity. The median overall survival and disease-free survival for the whole cohort was 140 days (range, 5-1,268). After a median follow-up of 681 days, the disease-free survival and overall survival rate was 85.7% and 85.7%, respectively, in the children. Despite engraftment in the 4 remaining adults, 1 died of fatal graft-vs.-host disease, 1 of infectious complications, 1 of disease relapse, and 1 of acute respiratory distress syndrome. Conclusions: In patients with graft failure or graft rejection after allogeneic hematopoietic stem cell transplantation, TLI-based reconditioning regimens allow sustained engraftment, paralleled by a favorable toxicity profile, potentially leading to long-term survival
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2007.06.037Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2007.06.037;
- PII
- S0360-3016(07)01157-1;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 70
- Journal Issue
- 2
- Journal Page Range
- p. 523-528
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 39059764
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANTIBODIES; BONE MARROW; CHILDREN; FAILURES; GLOBULINS; GRAFTS; INFUSION; IRRADIATION; LYMPHOCYTES; PATIENTS; RADIATION DOSES; STEM CELLS; TOXICITY
- Descriptors DEC
- AGE GROUPS; ANIMAL CELLS; ANIMAL TISSUES; ANIMALS; BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY; BODY FLUIDS; CONNECTIVE TISSUE CELLS; DOSES; HEMATOPOIETIC SYSTEM; INTAKE; LEUKOCYTES; MAMMALS; MAN; MATERIALS; ORGANIC COMPOUNDS; ORGANS; PRIMATES; PROTEINS; SOMATIC CELLS; TRANSPLANTS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2008 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved.